HROW FY 2017 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

FY 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$27M+34.3% YoY

Gross Profit

$13M49.6% margin

Operating Income

-$12M-45.4% margin

Net Income

-$12M-44.8% margin

EPS (Diluted)

$-0.60

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$10M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$24M

Total Liabilities

$21M

Stockholders' Equity

$3M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$20M	+34.3%
Gross Profit	$13M	$10M	+31.2%
Operating Income	-$12M	-$16M	+23.4%
Net Income	-$12M	-$19M	+37.2%